Table 1. Characteristics of sample, by treatment group and combined.

	CBT	Patient Education	Combined sample
	N, M(SD), n(%)	N, M(SD), n(%)	N, M(SD), n(%)
N	15	10	25
Age (years)	14.5 (2.1)	15.2 (2.0)	14.8 (2.1)
Gender
Female	10 (66.7%)	6 (60%)	16 (64%)
Male	5 (33.3%)	4 (40%)	9 (63%)
Race
Black or African American	14 (93.3%)	9 (90%)	23 (92%)
>1 race	1 (6.7%)	1 (10%)	2 (8%)
Ethnicity
Hispanic or Latino	1 (6.7%)	0	1 (4%)
Not Hispanic or Latino	13 (86.7%)	7 (70%)	20 (80%)
Other	1 (6.7%)	3 (30%)	4 (16%)
Annual household income
< $10,000	1 (6.7%)	2 (20%)	3 (12%)
$10,000 - $29,999	3 (20%)	7 (70%)	10 (40%)
$30,000 - $49,999	7 (46.7%)	0	7 (28%)
$50,000 - $69,999	3 (20%)	0	3 (12%)
$70,000 - $99,999	1 (6.7%)	1 (10%)	2 (8%)
Sickle Cell Genotype
SS	10 (66.7%)	7 (70)	17 (68%)
Sc	3 (20%)	1 (10%)	4 (16%)
S Beta Thal +	1 (6.7%)	0	1 (4%)
S Beta Thal o	0	2 (20%)	2 (8%)
Unsure	1 (6.7%)	0	1 (4%)
Taking Hydroxyurea
Yes	6 (40%)	8 (80%)	14 (56%)
No	9 (60%)	2 (20%)	11 (44%)
Regular blood transfusions
Yes	5 (33.3%)	1 (10%)	9 (24%)
No	10 (66.7%)	9 (90%)	16 (76%)
Caregiver involved in study
Mother	14 (93.3%)	9 (90%)	23 (92%)
Father	1 (6.7%)	0	1 (4%)
Grandmother	0	1 (10%)	1 (4%)